Skip to contentP
Precision Biosciences Inc
P
DTILPrecision Biosciences Inc Q2 2025 · 10-Q
Revenue$18.00K$18.00K−100.0% vs Q2 2024 Net Income-$23.52M-$23.52MN/M vs Q2 2024 EPS Diluted-$2.13-$2.13N/M vs Q2 2024 Operating Income-$21,877,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$20,273,000N/M Margins · derivedOperating margin-121538.9%−121587.3 pt vs Q2 2024
Net margin-130666.7%−130732.3 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 7, 2025 · 38 d after period end